Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

In Medtronic’s case specifically, the EY authors write, the company reported that its ability to predict and modulate supply ...

After a year of turmoil, Dallas Park and Recreation laid out their plans for managing Fair Park to a City Council committee ...

Ladies and gentlemen, good day, and welcome to Yuanbao Inc.'s Third Quarter 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I'd like to turn the conference over to ...

On October 25, 2025, the United States Court of Appeals for the Ninth Circuit reaffirmed a fundamental protection under the National Labor ...

The best-performing organizations have decision-makers who focus on clarity, accountability and support when implementing ...

Silver Beech Capital delivered 19.5% annualized returns since inception, navigating a market untethered from fundamentals.

In some parts of the world, record numbers of people are being diagnosed with attention deficit hyperactivity disorder (ADHD) ...

Supply chains lack the required “high-fidelity” data and capabilities to operate in today’s complex business climate that is ...

Vaccine advisers to the US Centers for Disease Control and Prevention are meeting today, and they could vote on possible changes to the childhood vaccination schedule. Follow here for live updates ...

Abstract: Databases form an inseparable part of the information systems. They hold the data formed by the data models. Data are operated by the database management system, which takes an interlayer ...

Long-term LEQEMBI treatment suggests potential to delay disease progression from Mild Cognitive Impairment (MCI) to moderate Alzheimer’s disease by up to 8.3 years in low-amyloid group who started ...